Listing 1 - 7 of 7 |
Sort by
|
Choose an application
Neuropathology --- Biopharmaco-efficiency. Pharmacokinetics --- Drug infusion pumps --- Nervous system --- Neuropharmacology --- Drugs --- Infusion Pumps --- Nervous System Diseases --- DRUGS --- INFUSION PUMPS --- NERVOUS SYSTEM DISEASES, drug therapy --- Congresses. --- Diseases --- Chemotherapy --- administration & dosage --- congresses. --- drug therapy --- administration and dosage --- Administration and dosage --- Administration & dosage --- Drug therapy --- Infusion pumps --- Nervous system diseases, drug therapy --- Nervous system diseases --- Congresses
Choose an application
Présentation de l'éditeur : "L'ouvrage Médicaments actifs sur le système nerveux central est consacré à l'étude des principales familles de médicaments utilisables dans les troubles neurologiques et neuropsychiatriques : structure des molécules, obtention, propriétés physico-chimiques, biotransformations, mécanisme d'action. Les approches thérapeutiques des désordres liés aux affections neurodégénératives et de ceux résultant de l'abus de quelques substances psychotropes sont également abordées."
Chemistry, Pharmaceutical --- Pharmaceutical Preparations --- Central Nervous System Agents --- Nervous System Diseases --- drug therapy --- Drugs --- Pharmaceutical chemistry --- Nervous system --- Chimie pharmaceutique --- Médicaments --- Médicaments du système nerveux central --- Système nerveux --- Diseases --- Chemotherapy --- Maladies --- Chimiothérapie --- Chemotherapy. --- Nervous System Diseases - drug therapy
Choose an application
Calcium --- Calcium Channel Blockers --- Cardiovascular Diseases --- Central Nervous System Diseases --- Ion Channels --- CALCIUM CHANNEL BLOCKERS, pharmacology --- CALCIUM CHANNEL BLOCKERS, therapeutic use --- CALCIUM --- CARDIOVASCULAR DISEASES, drug therapy --- CENTRAL NERVOUS SYSTEM DISEASES, drug therapy --- ION CHANNELS, physiology --- Antagonists --- Congresses. --- Therapeutic use --- pharmacology --- congresses. --- therapeutic use --- metabolism --- drug therapy --- physiology --- Metabolism --- Pharmacology --- Drug therapy --- Physiology --- Calcium channel blockers, pharmacology --- Calcium channel blockers, therapeutic use --- Cardiovascular diseases, drug therapy --- Central nervous system diseases, drug therapy --- Calcium channel blockers --- Cardiovascular diseases --- Central nervous system diseases --- Ion channels, physiology --- Ion channels
Choose an application
Dose-Response relationship, Drug --- Mental disorders --- Nervous system diseases --- Neuropsychopharmacology --- Psychotropic drugs --- Neuropsychopharmacologie --- Congresses --- Drug therapy --- Congrès --- Dose-Response Relationship, Drug --- Mental Disorders --- drug therapy --- Pharmacology --- Congresses. --- Textbooks & monographs 1891-2000 --- Textbooks & monographs 1891-2000. --- Congrès --- Nervous System Diseases --- Neuropsychopharmacology - Congresses --- Psychotropic drugs - Congresses --- Dose-Response Relationship, Drug - congresses --- Mental Disorders - drug therapy - congresses --- Nervous system diseases - Drug therapy - Congresses
Choose an application
Pharmacology. Therapy --- Neuropathology --- Monoamine Oxidase Inhibitors --- Monoamine oxidase --- Nerve Degeneration --- Nervous System Diseases --- Nervous system --- Parkinson's disease --- Selegiline. --- Pharmacology. --- Therapeutic use. --- Inhibitors --- Drug effects. --- Drug therapy. --- Degeneration --- Chemotherapy. --- Monoamine Oxydase Inhibitors --- Selegiline --- drug effects --- drug therapy --- Chemotherapy --- therapeutic use --- Nerve Degeneration - drug effects --- Nervous System Diseases - drug therapy --- Nervous system - Degeneration - Chemotherapy --- Monoamine oxidase - Inhibitors - therapeutic use --- Parkinson's disease - Chemotherapy
Choose an application
Neurotransmitters. --- Neurotransmitter receptors. --- Central Nervous System Agents --- Central Nervous System Diseases --- pharmacology. --- drug therapy. --- Neuropharmacology --- Neurotransmitter receptors --- Neurotransmitters --- Chemical nerve transmitters --- Nerve transmitter substances --- Neural transmitters --- Neurohumors --- Neuroregulators --- Synaptic transmitters --- Transmitters, Chemical nerve --- Transmitters, Synaptic --- Neurochemistry --- Neural transmission --- Receptors, Neurotransmitter --- Cell receptors --- Hormone receptors --- Neural receptors --- Nervous system --- Neurotropic drugs --- Neurosciences --- Pharmacology --- Drug effects --- Effect of drugs on --- Central Nervous System Agents - pharmacology. --- Central Nervous System Diseases - drug therapy.
Choose an application
Continuous rigorous research in basic neurosciences and in clinical studies has enormously increased our knowledge of the neurobiological basis of mental functions and of the neuronal dysfunctions underlying such diseases as schizophrenia, depression, attention deficit disorder, and Parkinson's disease. A transmitter system does not work in isolation, it interacts with other transmitters and the balance between several transmitter determines the outcome, either physiological or pathological. Such a critical balance exists between dopamine and glutamate, which in many brain areas play functionally opposing roles. In Dopamine and Glutamate in Psychiatric Disorders, a panel of neurochemists, pharmacologists, experimental psychologists, and clinicians summarizes our current understanding of the interactive role of dopamine and glutamate in psychiatric diseases and from that develops novel therapeutic strategies and possibilities for the future. Among the new ideas presented are hypotheses on the role of dopamine and glutamate in aggression, the glutamate system in anxiety disorders, glutamate and neurodegeneration, on the origin, progression, and cognitive aspects of Parkinson's disease. Additional chapters offer illuminating insights into a variety of psychiatric diseases, including attention deficit hyperactivity disorder, stress, aggression, addiction, schizophrenia, depression, social phobias, dementias, bulimia, and neurodegenerative diseases like Parkinson's and Alzheimer's diseases. Each chapter summarizes the prevalence and symptoms of the disease and explains the involvement of dopamine and/or glutamate systems using the newer molecular approaches such as transgenic knockout or knockin mice and recent brain imaging techniques. The authors also offer a critical selection and evaluation of relevant literature and a description of future directions for new therapy development. Path-breaking and insightful, Dopamine and Glutamate in Psychiatric Disorders offers behavioral pharmacologists, neurobiologists, and clinicians an enlightening review of the neurobiological basis and treatment strategies of today's most important psychiatric and neurological diseases.
Medicine & Public Health. --- Psychiatry. --- Medicine. --- Médecine --- Psychiatrie --- Antidepressive Agents -- pharmacology. --- Antipsychotic Agents -- pharmacology. --- Dopamine -- Pathophysiology. --- Glutamate -- Pathophysiology. --- Mental Disorders -- drug therapy. --- Mental Disorders -- etiology. --- Nervous System Diseases -- drug therapy. --- Nervous System Diseases -- etiology. --- Neuropsychiatry. --- Neurotransmitter receptors. --- Neuropsychiatry --- Dopamine --- Glutamate --- Neurotransmitter receptors --- Tranquilizing Agents --- Receptors, Catecholamine --- Amino Acids, Dicarboxylic --- Psychiatry and Psychology --- Psychotropic Drugs --- Excitatory Amino Acids --- Receptors, Amino Acid --- Diseases --- Amino Acids, Acidic --- Catecholamines --- Central Nervous System Agents --- Amino Acids --- Receptors, Biogenic Amine --- Central Nervous System Depressants --- Biogenic Monoamines --- Receptors, Neurotransmitter --- Receptors, G-Protein-Coupled --- Amines --- Amino Acids, Peptides, and Proteins --- Receptors, Cell Surface --- Biogenic Amines --- Organic Chemicals --- Physiological Effects of Drugs --- Therapeutic Uses --- Pharmacologic Actions --- Membrane Proteins --- Chemicals and Drugs --- Proteins --- Chemical Actions and Uses --- Antidepressive Agents --- Antipsychotic Agents --- Mental Disorders --- Glutamic Acid --- Receptors, Dopamine --- Receptors, Glutamate --- Nervous System Diseases --- Medicine --- Psychiatry --- Health & Biological Sciences --- Neurology --- Psychiatry - General --- Pathophysiology --- Glutamic acid --- Pathophysiology. --- Behavioral neurology --- Medicine and psychology --- Mental health --- Psychology, Pathological --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Excitatory amino acids --- Umami (Taste) --- Biogenic amines --- Bromocriptine --- Neurotransmitters --- Biological psychiatry --- Cell receptors --- Hormone receptors --- Neural receptors
Listing 1 - 7 of 7 |
Sort by
|